Similarly, PSMB1, the non-catalytic component of the proteasome complex, was implicated in poor survival outcomes across several cancer types (Fig. 3c), namely bladder urothelial carcinoma (BLCA), BRCA, HNSC and lung adenocarcinoma (LUAD). The gene discussed is PSMB1; the disease is lung adenocarcinoma.